Global /India /Healthcare /Drug Manufacturers - General /VENUSREM

Venus Remedies Ltd.

VENUSREM

• NSE: VENUSREM • Delayed

967.40INR 3.7%

10.25 USD

As of 20 June 2026, Venus Remedies Ltd. has a market cap of $132.1M USD, ranking #23679 globally and #1405 in India. It ranks #2129 in the Healthcare sector, and #771 in the Drug Manufacturers - General industry.

Global Rank

23679

Country Rank

1405

Sector Rank

2129

Industry Rank

771

Key Stats

Market Cap

$132.1MUSD

12.47B INR

Enterprise Value

$108.61MUSD

10.25B INR

Revenue (TTM)

$74.47MUSD

7.03B INR

EBITDA (TTM)

$11.69MUSD

1.1B INR

Net Income (TTM)

$8.08MUSD

762.85M INR

EBITDA Margin

16%

Profit Margin

11%

PE Ratio

16.3

PS Ratio

1.8

PB Ratio

2.1

EV/EBITDA

9.3

Company Profile

Country (HQ)

India

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Ashutosh Jain open_in_new

Employees

1,298

Founded

1989

Website

venusremedies.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
3.7%	-8.9%	8.2%	25%	114%	22%	198%	368%	196%

News

Markets

Exchange	Ticker	Price	Quotes
National Stock Exchange of India (NSE) MIC: XNSE PRIMARY	VENUSREM Venus Remedies Ltd ISIN: INE411B01019 Shares Out.: Shares Outstanding: 13.367M¹ Shares Float: 6.869M² TV: TradingView: NSE: VENUSREM SA: Stock Analysis: NSE: VENUSREM YF: Yahoo Finance: VENUSREM.NS GF: Google Finance: NSE: VENUSREM BA: Barron's: VENUSREM MS: Morningstar: XNSE: VENUSREM	967.40 INR	TV: TradingView: NSE: VENUSREM SA: Stock Analysis: NSE: VENUSREM YF: Yahoo Finance: VENUSREM.NS GF: Google Finance: NSE: VENUSREM BA: Barron's: VENUSREM MS: Morningstar: XNSE: VENUSREM
Bombay Stock Exchange (BSE / BOM) MIC: XBOM	526953 (VENUSREM) Venus Remedies Ltd ISIN: INE411B01019 TV: TradingView: BSE: VENUSREM SA: Stock Analysis: BOM: 526953 YF: Yahoo Finance: 526953.BO GF: Google Finance: BOM: 526953 BA: Barron's: 526953 MS: Morningstar: XBOM: 526953	932.75 INR	TV: TradingView: BSE: VENUSREM SA: Stock Analysis: BOM: 526953 YF: Yahoo Finance: 526953.BO GF: Google Finance: BOM: 526953 BA: Barron's: 526953 MS: Morningstar: XBOM: 526953

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Venus Remedies Ltd.

Venus Remedies Limited engages in the pharmaceutical business in India and internationally. It is involved in the research and development of solutions focusing on antimicrobial resistance and oncology. The company also offers analgesic, analgesic and antipyretic, antibiotic, anticoagulant, antiemetic, antiviral, cardiovascular, disinfectant and antiseptic, gastro therapy, hepatoprotective, hormones (steroid), immunostimulating agent, iron supplements, muscle relaxant, neurology, oncology, and solvent products, as well as herbal medicine. The company was incorporated in 1989 and is headquartered in Panchkula, India.

Similar Companies

Industry: Drug Manufacturers - General (India)

Name	Market Cap (USD) diff.	PE	Country
Sun Pharmaceutical Industries Ltd. NSE: SUNPHARMA	$45.22B 4.27T INR 34K%	39.1	India
Divi's Laboratories Ltd. NSE: DIVISLAB	$18.38B 1.73T INR 14K%	70.0	India
Torrent Pharmaceuticals Ltd. NSE: TORNTPHARM	$15.17B 1.43T INR 11K%	63.0	India
Dr. Reddy's Laboratories Ltd. NSE: DRREDDY	$11.73B 1.11T INR 9K%	19.6	India
Mankind Pharma Ltd. NSE: MANKIND	$9.87B 931.67B INR 7K%	52.2	India
Zydus Lifesciences Ltd. NSE: ZYDUSLIFE	$9.71B 916.53B INR 7K%	18.6	India

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 577K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 414K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 273K%	97.4	United States
Roche Holding AG SIX: RO	$318.3B 256.25B CHF 241K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$284.64B 215.59B GBP 215K%	27.6	United Kingdom
Merck & Co., Inc. NYSE: MRK	$274.03B 207K%	15.1	United States

chevron_leftBack